World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
11394
World Ranking
4578
National Ranking
2063

Krisha McKee publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Krisha McKee sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 103 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Krisha McKee D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Krisha McKee sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Krisha McKee is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily contributes to the fields of Immunology and Microbiology, Medicine, as well as Biochemistry, Genetics and Molecular Biology. Within these areas, McKee has a notable focus on Virology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, and Infectious Diseases.

The scientist's main research topics include HIV Research and Treatment, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, HIV/AIDS drug development and treatment, vaccines and immunoinformatics approaches, Immune Cell Function and Interaction, and T-cell and B-cell Immunology.

McKee has published multiple papers in various academic journals. Some of the recent notable publications include:

  • "Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody," 2020, Proceedings of the National Academy of Sciences
  • "Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition," 2020, Cell Reports
  • "Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen," 2020, Scientific Reports
  • "Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys," 2022, Cell Reports
  • "A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention," 2021, mAbs

Frequent co-authors collaborating with McKee include:

  • Nicole A. Doria-Rose
  • Baoshan Zhang
  • Peter D. Kwong
  • Mark K. Louder
  • John R. Mascola

Common publication venues for McKee's research are:

  • Cell Reports
  • mAbs
  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports

Best Publications

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies.

    Tongqing Zhou;Jiang Zhu;Xueling Wu;Stephanie Moquin

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Rui Kong;Kai Xu;Tongqing Zhou;Priyamvada Acharya

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    Rebecca S. Rudicell;Young Do Kwon;Sung-Youl Ko;Amarendra Pegu

  • Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

    Ling Xu;Amarendra Pegu;Ercole Rao;Nicole Doria-Rose

  • Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

    K. Xu;P. Acharya;R. Kong;C. Cheng

  • Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01

    Yuxing Li;Sijy O'Dell;Laura M. Walker;Xueling Wu

  • Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

    Xueling Wu;Xueling Wu;Zhenhai Zhang;Chaim A. Schramm;M. Gordon Joyce

  • New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    Nicole A. Doria-Rose;Jinal N. Bhiman;Jinal N. Bhiman;Ryan S. Roark;Chaim A. Schramm

  • Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

    Mattia Bonsignori;Mattia Bonsignori;Edward F. Kreider;Daniela Fera;R. Ryan Meyerhoff;R. Ryan Meyerhoff

  • Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.

    Ivelin S. Georgiev;Nicole A. Doria-Rose;Tongqing Zhou;Young Do Kwon

  • Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

    Amarendra Pegu;Zhi Yong Yang;Jeffrey C. Boyington;Lan Wu

  • Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.

    Tongqing Zhou;Nicole A. Doria-Rose;Cheng Cheng;Guillaume B.E. Stewart-Jones

  • Mining the antibodyome for HIV-1–neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains

    Jiang Zhu;Gilad Ofek;Yongping Yang;Baoshan Zhang

  • Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site

    Ema T. Crooks;Tommy Tong;Bimal Chakrabarti;Kristin Narayan

  • Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.

    La Tonya D. Williams;Gilad Ofek;Sebastian Schätzle;Jonathan R. McDaniel

  • Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

    Kai Xu;Priyamvada Acharya;Rui Kong;Cheng Cheng

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Mark K. Louder
Mark K. Louder National Institute of Allergy and Infectious Diseases
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
Nicole A. Doria-Rose
Nicole A. Doria-Rose National Institute of Allergy and Infectious Diseases
Lawrence Shapiro
Lawrence Shapiro Columbia University
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Richard T. Wyatt
Richard T. Wyatt Scripps Research Institute
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Baoshan Zhang
Baoshan Zhang National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related degrees and career pathways can broaden professional opportunities. Many students consider transitioning within healthcare fields, such as moving from a Family Nurse Practitioner to specialized roles. Programs like the fnp to acute care np bridge program offer tailored pathways to gain advanced clinical skills in acute care settings.

Accelerated programs provide a fast-track option for students aiming to enter nursing specialties quickly. The accelerated nurse practitioner program options available online are designed to prepare candidates efficiently for advanced practice roles.

For individuals without a nursing background, exploring online absn programs for non nurses can be an excellent entry point into nursing with flexible learning formats. These programs are crafted to help non-nurses gain essential clinical knowledge and licensure preparation in a streamlined fashion.

Additionally, applicants looking for accessibility might consider absn programs with high acceptance rates, which provide more inclusive admissions while maintaining quality education. This variety of online degree options supports diverse career trajectories related to Immunology and healthcare.

Best Scientists Citing Krisha McKee

Trending Scientists

Recently Published Articles